Novartis Finds Several Japan Trials Included An Employee's Involvement
This article was originally published in PharmAsia News
Executive Summary
More Japan clinical trials of Novartis Pharma's Valsartan (amlodipine) blood-pressure drug in Japan may be questioned in light of revelations an employee known to have been involved in one actually was involved in at least four.